<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The adipocytokine apelin is a <z:chebi fb="7" ids="16670">peptide</z:chebi> that was isolated from a bovine stomach for the first time </plain></SENT>
<SENT sid="1" pm="."><plain>This <z:chebi fb="7" ids="16670">peptide</z:chebi> and its receptor are abundantly expressed in the <z:mp ids='MP_0008912'>nervous</z:mp> and cardiovascular systems </plain></SENT>
<SENT sid="2" pm="."><plain>According to previous studies, apelin-13 protects cardiomyocytes from ischemic injury as well as <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, this <z:chebi fb="7" ids="16670">peptide</z:chebi> has a neuroprotective effect on hippocampal and cultured mouse cortical neurons against <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor-mediated excitotoxicity </plain></SENT>
<SENT sid="4" pm="."><plain>The present study was conducted to determine whether apelin-13 provides protection in transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by 60-min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), followed by 23-h reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>Saline as a vehicle and apelin-13 at doses of 25, 50, and 100 μg were injected intracerebroventriculary (ICV) at the beginning of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume ,<z:hpo ids='HP_0002181'>brain edema</z:hpo>, motor dysfunction, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were assessed 24 h after MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment with apelin-13 at doses of 50 and 100 μg ICV markedly reduced total <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes by 45 and 55 %, respectively (P &lt; 0.001), but injection of apelin at lower dose (25 μg) did not change <z:mpath ids='MPATH_124'>infarct</z:mpath> volume significantly (P &gt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, apelin-13 at doses of 50 and 100 μg reduced <z:hpo ids='HP_0002181'>brain edema</z:hpo> (P &lt; 0.001) and inhibited <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by decreasing caspase-3 activation (P &lt; 0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>Apelin-13 did not significantly change neurological dysfunction (P &gt; 0.05) </plain></SENT>
</text></document>